Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Liabilities from Discontinued Operations (2017)

Fortress Biotech has reported Liabilities from Discontinued Operations over the past 1 years, most recently at 29283000.0 for Q4 2017.

  • Quarterly results put Liabilities from Discontinued Operations at 29283000.0 for Q4 2017, changed N/A from a year ago — trailing twelve months through Dec 2017 was 29283000.0 (changed N/A YoY), and the annual figure for FY2017 was 29283000.0, changed.
  • Liabilities from Discontinued Operations for Q4 2017 was 29283000.0 at Fortress Biotech.
  • Over the last five years, Liabilities from Discontinued Operations for FBIO hit a ceiling of 29283000.0 in Q4 2017 and a floor of 29283000.0 in Q4 2017.